Lyme Disease as a Cause of Musculoskeletal Ache with Arm Movement
Lyme disease should be strongly considered in patients with musculoskeletal aches and documented tick exposure, particularly in endemic areas, as early Lyme disease commonly presents with migratory musculoskeletal pain affecting joints, tendons, and muscles that can last hours to days in a given location before moving elsewhere. 1
Key Clinical Features Supporting Lyme Disease
Early Musculoskeletal Manifestations
- Migratory pain pattern is characteristic: Early in Lyme disease, patients experience musculoskeletal pain in joints, bursae, tendons, muscle, or bone in one or a few locations at a time, frequently lasting only hours or days in a given location before moving. 1
- Diffuse, nonspecific muscle achiness and stiffness can appear early in the disease course, often before more specific manifestations develop. 2
- These early symptoms typically occur within days to weeks after tick exposure and may be accompanied by fever, headache, malaise, and myalgia. 3
Critical Diagnostic Clues from History
- Tick exposure is essential: Query specifically about recent recreational or occupational activities that might reveal potential exposure to ticks, including exposure in the patient's backyard or neighborhood. 3
- Endemic area residence or travel: Approximately 90% of Lyme disease cases are reported from 140 counties along the northeastern and mid-Atlantic seaboard and in the upper north-central United States. 3
- Timing matters: Most patients visit a physician during the first 2-4 days of illness, after an incubation period of approximately 5-10 days after a tick bite. 3
Physical Examination Priorities
- Search for erythema migrans (EM): This expanding annular rash occurs in 70-80% of Lyme disease cases and is the hallmark of early infection, typically appearing within 7-14 days after tick bite. 3, 4
- EM can be located in the axilla, groin, cubital area, or around the waist—areas that should be specifically examined even if the patient's chief complaint is arm pain. 4
- Only 25% of patients recall the actual tick bite, so absence of this history does not exclude Lyme disease. 4
- Regional lymphadenopathy may be present and supports the diagnosis. 4
Differentiating from Other Conditions
Distinguishing from Fibromyalgia
- Objective findings favor Lyme disease: The CDC recommends prioritizing objective clinical findings over subjective complaints, with Lyme disease requiring documented erythema migrans, objective arthritis, or neurologic abnormalities, while fibromyalgia presents with widespread musculoskeletal pain and multiple tender points. 5
- If only subjective symptoms such as pain, fatigue, or paresthesias exist without objective findings, fibromyalgia is more likely than active Lyme disease. 5
- Lyme disease may occasionally trigger fibromyalgia as a chronic pain syndrome, but this does not respond to antibiotic therapy. 1
Ruling Out Coinfections
- The tick vector Ixodes scapularis also transmits Anaplasma phagocytophilum and Babesia microti, making coinfection possible. 3
- If leukopenia or thrombocytopenia is present, consider coinfection with Anaplasma phagocytophilum, as these laboratory abnormalities are characteristic of anaplasmosis but not typical of Lyme disease alone. 3
- Ehrlichiosis presents predominantly with fever, headache, malaise, and myalgia, with rash in only one-third of patients, and is transmitted by Amblyomma americanum (lone star tick) in southeastern and south-central United States. 6
Diagnostic Approach
When to Test
- Clinical diagnosis suffices for erythema migrans: Clinical findings alone are sufficient for diagnosis of erythema migrans in endemic areas with appropriate exposure history. 3
- Laboratory confirmation needed for extracutaneous manifestations: Diagnostic testing in laboratories with excellent quality-control procedures is required for confirmation of extracutaneous Lyme disease. 3
- The CDC recommends considering Lyme disease if a patient has objective arthritis and is in an endemic area with tick exposure within 30 days. 5
Testing Strategy
- Two-tier serologic testing (ELISA followed by Western blot) is the preferred diagnostic strategy for extracutaneous manifestations. 5, 7
- Serology may be negative early in infection (first 2-4 weeks), so a negative test does not exclude early Lyme disease if EM is present. 3
- Testing is NOT recommended for nonspecific neurologic or musculoskeletal symptoms without other clinical or epidemiologic support for Lyme disease. 7
Treatment Recommendations
For Early Localized Disease with Musculoskeletal Symptoms
- Doxycycline 100 mg twice daily for 14-21 days is preferred for early Lyme disease in adults and children ≥8 years old. 6
- Amoxicillin 500 mg three times daily for 14-21 days is an alternative for early-stage disease, particularly in pregnant women and children <8 years old. 6, 4
- Treatment should be initiated based on clinical diagnosis of EM without waiting for serologic confirmation. 3
Expected Response
- Early musculoskeletal symptoms typically resolve with appropriate antibiotic therapy. 1
- If symptoms persist despite treatment with doxycycline, consider coinfection with Anaplasma phagocytophilum, as amoxicillin is not effective for ehrlichiosis or anaplasmosis. 6
Critical Pitfalls to Avoid
- Do not dismiss the diagnosis based on absence of recalled tick bite: Only 25% of patients remember the tick bite. 4
- Do not wait for arthritis to develop: Migratory musculoskeletal pain is an early manifestation; intermittent or chronic arthritis typically develops weeks to months later in untreated patients. 1
- Do not overlook examination of typical EM locations: Even if the patient complains of arm pain, examine axillae, groin, and other common sites for EM. 4
- Do not order Lyme testing for nonspecific symptoms without epidemiologic support: This leads to false-positive results and inappropriate treatment. 7
- Do not use prolonged or recurrent antibiotic courses: There is no evidence that prolonged treatment changes the natural history of Lyme disease. 8